Peripheral orphanin FQ/Nociceptin analgesia in the mouse

被引:42
作者
Kolesnikov, YA
Pasternak, GW
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, Cotzias Lab Neurooncol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol, New York, NY 10021 USA
关键词
opioid; anti-opioid; topical; opioid receptor; ORL1; KOR-3;
D O I
10.1016/S0024-3205(99)00149-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Orphanin FQ/Nociceptin (OFQ/N) administered peripherally was an effective analgesic in the tailflick test in mice (ED50 16.3 mu g). It had a peak effect at 5 min and lasted up to 30 min. The kappa, analgesic naloxone benzoylhydrazone was also active peripherally (ED50 3.8 mu g). The analgesic actions of both agents were blocked by naloxone. Neither OFQ/N(1-11) nor OFQ/N(1-7) had appreciable peripheral activity. Antisense mapping both compounds against the murine orphan opioid receptor (KOR-3) confirmed the importance of this clone in their actions. Antisense probes targeting the second and third coding exons significantly lowered the analgesic effects of both compounds. However, the antisense targeting the first coding exon blocked only the actions of OFQ/N and not kappa, analgesia.
引用
收藏
页码:2021 / 2028
页数:8
相关论文
共 24 条
  • [1] Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide
    Grisel, JE
    Mogil, JS
    Belknap, JK
    Grandy, DK
    [J]. NEUROREPORT, 1996, 7 (13) : 2125 - 2129
  • [2] Characterization of nociceptin hyperalgesia and allodynia in conscious mice
    Hara, N
    Minami, T
    OkudaAshitaka, E
    Sugimoto, T
    Sakai, M
    Onaka, M
    Mori, H
    Imanishi, T
    Shingu, K
    Ito, S
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (03) : 401 - 408
  • [3] Spinal analgesic activity of orphanin FQ/nociceptin and its fragments
    King, MA
    Rossi, GC
    Chang, AH
    Williams, L
    Pasternak, GW
    [J]. NEUROSCIENCE LETTERS, 1997, 223 (02) : 113 - 116
  • [4] Peripheral kappa(1)-opioid receptor-mediated analgesia in mice
    Kolesnikov, Y
    Jain, S
    Wilson, R
    Pasternak, GW
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 310 (2-3) : 141 - 143
  • [5] Kolesnikov YA, 1996, J PHARMACOL EXP THER, V279, P502
  • [6] IRREVERSIBLE OPIATE AGONISTS AND ANTAGONISTS .5. HYDRAZONE AND ACYLHYDRAZONE DERIVATIVES OF NALTREXONE
    LUKE, MC
    HAHN, EF
    PRICE, M
    PASTERNAK, GW
    [J]. LIFE SCIENCES, 1988, 43 (15) : 1249 - 1256
  • [7] ISOLATION AND STRUCTURE OF THE ENDOGENOUS AGONIST OF OPIOID RECEPTOR-LIKE ORL(1) RECEPTOR
    MEUNIER, JC
    MOLLEREAU, C
    TOLL, L
    SUAUDEAU, C
    MOISAND, C
    ALVINERIE, P
    BUTOUR, JL
    GUILLEMOT, JC
    FERRARA, P
    MONSARRAT, B
    MAZARGUIL, H
    VASSART, G
    PARMENTIER, M
    COSTENTIN, J
    [J]. NATURE, 1995, 377 (6549) : 532 - 535
  • [8] Orphanin FQ is a functional anti-opioid peptide
    Mogil, JS
    Grisel, JE
    Reinscheid, RK
    Civelli, O
    Belknap, JK
    Grandy, DK
    [J]. NEUROSCIENCE, 1996, 75 (02) : 333 - 337
  • [9] MOGIL JS, 1996, NEUROSCI LETT, V214, P1
  • [10] Nocistatin, a peptide that blocks nociceptin action in pain transmission
    Okuda-Ashitaka, E
    Minami, T
    Tachibana, S
    Yoshihara, Y
    Nishiuchi, Y
    Kimura, T
    Ito, S
    [J]. NATURE, 1998, 392 (6673) : 286 - 289